James Yang Liu - 28 Sep 2025 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (OCX)

Reporting relationship: VP ACCT, Cntlr, Treasurer, PAO
Issuer ticker: OCX
Reported as of: 28 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Sep 2025, 17:01:07 UTC
Prior SEC filing: 28 Mar 2025
Next SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ James Liu

Key filing fact

James Yang Liu filed Form 4 for Insight Molecular Diagnostics Inc. (OCX) on 30 Sep 2025.

Key facts

This page summarizes James Yang Liu's Form 4 filing for Insight Molecular Diagnostics Inc. (OCX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 Sep 2025, 17:01.

Change

Previous filing in this sequence was filed on 28 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001944774 Primary reporting owner

Liu James Yang

Relationship: VP ACCT, Cntlr, Treasurer, PAO
Address: C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE
Signature: /s/ James Liu
Signature date: 30 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMDX transaction Derivative

Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +18,000
Change %
Price: $0.000000
Shares after: 18,000
Date: 28 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,000
Exercise price: $3.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.